ARISTOTLE: A phase III trial comparing concurrent capecitabine with capecitabine and irinotecan (Ir) chemoradiation as preoperative treatment for MRI-defined locally advanced rectal cancer (LARC).

David Sebag-Montefiore; Richard Adams; Simon Bach

ARISTOTLE: A phase III trial comparing concurrent capecitabine with capecitabine and irinotecan (Ir) chemoradiation as preoperative treatment for MRI-defined locally advanced rectal cancer (LARC).

David Sebag-Montefiore
, Richard Adams
, Simon Bach

Cancer and Genomic Sciences

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	4101-410
Number of pages	9
Journal	Journal of Clinical Oncology
Publication status	Published - 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Cite this

@article{f9ec53f4a9234dbf999ea599e1754ad5,

title = "ARISTOTLE: A phase III trial comparing concurrent capecitabine with capecitabine and irinotecan (Ir) chemoradiation as preoperative treatment for MRI-defined locally advanced rectal cancer (LARC).",

author = "David Sebag-Montefiore and Richard Adams and Simon Bach",

year = "2020",

language = "English",

pages = "4101--410",

journal = "Journal of Clinical Oncology ",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

}

ARISTOTLE: A phase III trial comparing concurrent capecitabine with capecitabine and irinotecan (Ir) chemoradiation as preoperative treatment for MRI-defined locally advanced rectal cancer (LARC). / Sebag-Montefiore, David; Adams, Richard; Bach, Simon.
In: Journal of Clinical Oncology , 2020, p. 4101-410.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - ARISTOTLE: A phase III trial comparing concurrent capecitabine with capecitabine and irinotecan (Ir) chemoradiation as preoperative treatment for MRI-defined locally advanced rectal cancer (LARC).

AU - Sebag-Montefiore, David

AU - Adams, Richard

AU - Bach, Simon

PY - 2020

Y1 - 2020

M3 - Article

SN - 0732-183X

SP - 4101

EP - 4410

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

ER -